The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The China castor oil market exhibited moderate growth during 2014-2019. Castor oil is derived from an oilseed crop, which is cultivated in arid and semi-arid regions. It has a high-ricinoleic acid content and provides excellent lubrication properties. As a result, it finds application in the production of perfumes, medicines, soaps, surface coatings, toiletries and cosmetics. Besides this, castor oil is employed in the pharmaceuticals sector as it is highly effective against constipation.
The increasing utilization of castor oil for relieving various health concerns, along with its therapeutic, preventive, and curative properties, is strengthening the market growth in China. Moreover, due to the anti-bacterial and anti-inflammatory attributes of castor oil, it is widely utilized as a massage oil for easing arthritic joints, nerve inflammations and sore muscles. Apart from this, the rising geriatric population, in confluence with the escalating demand for chemical derivatives of castor oil, such as hydrogenated oil (HCO), dehydrated oil (DCO) and sebacic acid, are propelling the market growth in the country. However, with the sudden outbreak of coronavirus disease (COVID-19) and lockdowns imposed in different regions, various manufacturing units are under temporary closure. The market is anticipated to experience growth once lockdown relaxations are introduced. Looking forward, IMARC Group expects the market to continue its moderate growth during the next five years.
IMARC Group provides an analysis of the key trends in each sub-segment of the China castor oil market report, along with forecasts for growth at the region level from 2020-2025. Our report has categorized the market based on region and end use.
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at